Hydrocephalus in Adults: Diagnosis and Treatment Options
Hydrocephalus occurs when cerebrospinal fluid (CSF) accumulates within the brain’s ventricular system and disrupts normal pressure, circulation, or absorption. Although commonly associated with infants, it can develop at any age. In adults, symptoms may be subtle, progressive, or mistaken for ageing, depression, Parkinson’s disease, medication effects, or recovery from another illness.
The condition has several forms. Obstructive hydrocephalus results from a blockage within the CSF pathways, while communicating hydrocephalus occurs when fluid absorption is impaired after the CSF has circulated through the ventricles. Normal pressure hydrocephalus (NPH) is a particularly important adult syndrome because ventricular enlargement may occur without a persistently high measured pressure.
Adult hydrocephalus can follow subarachnoid haemorrhage, head injury, meningitis, brain tumours, congenital narrowing of the aqueduct, stroke, or previous neurosurgery. Some patients have no clear precipitating cause. The diagnosis depends on the pattern of symptoms, neurological examination, brain imaging, and carefully selected tests rather than on a scan alone.
In Australia, assessment often begins with a general practitioner, emergency department, or neurologist before referral to a neurosurgical service. Patients in Sydney, Melbourne, Brisbane, Perth, Adelaide and other major centres may have access to specialist clinics, while people in regional or remote communities may require coordinated imaging, telehealth review, and travel to a tertiary hospital. Understanding the reasoning behind each test and treatment can make this process less confusing.
Recognising Symptoms in Adults
Symptoms vary according to how quickly CSF builds up, the underlying cause, and the person’s neurological reserve. Acute hydrocephalus may cause severe headache, nausea, vomiting, drowsiness, visual disturbance, or a rapid decline in consciousness. This is an emergency, particularly when it follows a head injury, intracranial bleeding, infection, or a known brain tumour.
More gradual hydrocephalus can present with impaired balance, slowed walking, urinary urgency, reduced concentration, memory problems, personality change, or daytime sleepiness. In normal pressure hydrocephalus, the classic pattern is gait disturbance, cognitive decline, and urinary symptoms. The walking difficulty often appears first: patients may take short steps, shuffle, feel unsteady when turning, or have trouble rising from a chair.
Symptoms can overlap with common disorders in older adults. Arthritis may explain slow walking, while prostate disease or urinary infection may account for urgency. Depression and sleep disorders can affect concentration. For this reason, a diagnosis of NPH should not be based on the triad alone. A detailed timeline, collateral history from family, medication review, and assessment of functional change are valuable.
Sudden deterioration, repeated vomiting, new weakness, seizure, severe headache, unequal pupils, or reduced alertness requires urgent emergency assessment. In Australia, calling Triple Zero (000) is appropriate when a person appears acutely neurologically unwell rather than waiting for a routine GP appointment.
How Clinicians Confirm the Diagnosis
The initial assessment includes a neurological examination, gait observation, cognitive screening, eye examination, and review of previous illnesses or operations. Clinicians may ask about falls, bladder control, driving, work performance, headaches, sleep, and changes noticed by relatives. Comparing current function with earlier videos or clinical records can help when the decline has been gradual.
CT of the brain is often the first imaging test in an emergency because it is fast and widely available. MRI provides greater detail about the ventricles, surrounding brain tissue, obstruction, previous bleeding, white-matter disease, and other causes of cognitive or gait change. Common imaging findings include enlarged ventricles, but ventricular enlargement alone does not establish that CSF diversion will help.
In suspected NPH, doctors may use a lumbar puncture, sometimes called a tap test, to remove a measured volume of CSF and then reassess walking or cognition. Formal gait testing before and after the procedure can make a small improvement easier to detect. An extended lumbar drainage trial may be considered when the diagnosis remains uncertain, although it requires monitoring and carries procedural risks.
CSF pressure measurements, ophthalmological assessment, neuropsychological testing, and specialised MRI techniques may add information in selected cases. A multidisciplinary review can be particularly useful where vascular disease, Parkinsonism, Alzheimer’s disease, spinal problems, or medication effects could explain some of the symptoms.
Treatment Pathways and Surgical Choices
Treatment depends on the type and cause of hydrocephalus. Acute obstructive hydrocephalus may require urgent external ventricular drainage, which temporarily diverts CSF through a catheter to a sterile collection system. This can reduce dangerous pressure while clinicians treat the underlying blockage, bleeding, infection, or tumour.
For longer-term management, a ventriculoperitoneal (VP) shunt is the most common diversion procedure. It drains CSF from a cerebral ventricle through a valve and catheter into the peritoneal cavity, where the fluid can be absorbed. Adjustable valves allow clinicians to modify drainage settings after surgery, which may be useful when symptoms or imaging change over time. Ventriculoatrial or lumboperitoneal shunts are alternatives in selected situations.
Endoscopic third ventriculostomy (ETV) creates an opening in the floor of the third ventricle, allowing CSF to bypass an obstruction. It is most suitable for certain forms of non-communicating hydrocephalus, such as aqueductal stenosis, and is not a universal alternative to shunting. Patient age, anatomy, previous operations, cause of hydrocephalus, and the likelihood of restoring CSF absorption all influence the decision.
A practical clinical management perspective can complement formal guidelines and individual specialist advice, but treatment must be tailored to the patient. A neurosurgeon should explain the expected benefit, possible need for revision, anaesthetic considerations, infection risk, bleeding, seizures, over-drainage, and the possibility that symptoms have another cause.
Living With a Shunt and Monitoring Recovery
After shunt surgery, recovery is assessed through function rather than imaging alone. Walking speed, balance, transfers, continence, alertness, and ability to manage everyday tasks may improve at different rates. Physiotherapy and occupational therapy can help patients regain strength, practise safe transfers, and adapt the home environment. Cognitive recovery may be slower or incomplete, especially when vascular or degenerative disease is present.
Shunt complications include infection, blockage, under-drainage, over-drainage, subdural collections, and mechanical failure. Over-drainage may cause postural headache, nausea, dizziness, or a subdural haematoma. A blocked or infected shunt can lead to worsening headache, vomiting, drowsiness, fever, neck stiffness, or a return of previous symptoms. These signs require prompt medical review rather than adjustment of the valve without specialist supervision.
Patients should keep details of the shunt type and valve setting, particularly when travelling or undergoing MRI. Many modern programmable valves are MRI-compatible under specified conditions, but the setting may need to be checked after the scan. Carrying a medical alert card or recording the device details in a phone can assist emergency and radiology teams.
In Australia, follow-up may involve a public hospital neurosurgical clinic, a private specialist, a neurologist, a rehabilitation service, or a GP coordinating care closer to home. Access can differ between metropolitan and rural areas. Some people face delays for elective appointments in the public system, while private health insurance may affect the choice of hospital and timing. These practical factors should be discussed early, especially when symptoms are progressing.
Weighing Benefits, Risks, and Alternatives
The potential benefit of CSF diversion is greatest when symptoms, imaging, and physiological testing point in the same direction. A patient with a typical gait disorder, supportive MRI findings, and measurable improvement after CSF removal may be a stronger candidate for shunting than someone with isolated memory loss and extensive alternative explanations.
No test predicts outcome perfectly. A negative tap test does not always exclude benefit, particularly when the procedure was technically difficult or the assessment was incomplete. Conversely, temporary improvement after lumbar drainage can occur without durable benefit from surgery. Shared decision-making should consider baseline independence, frailty, other neurological disease, goals of care, and the risks of anaesthesia and long-term device management.
| Clinical situation | Common assessment | Possible treatment direction |
|---|---|---|
| Acute deterioration with ventricular enlargement | Urgent CT, neurological review, search for bleeding, tumour, or infection | External ventricular drainage and treatment of the underlying cause |
| Obstructive hydrocephalus | MRI to identify the blockage and ventricular anatomy | ETV, shunt, or treatment of the obstructing lesion |
| Suspected normal pressure hydrocephalus | Gait and cognitive assessment, MRI, tap test or lumbar drainage | Consideration of VP shunt when evidence and goals align |
| Shunt-related headache or decline | Examination, CT or MRI, valve and shunt assessment | Valve adjustment, revision, drainage, or treatment of a complication |
| Ventricular enlargement with minimal symptoms | Clinical monitoring and investigation for alternative diagnoses | Observation and follow-up rather than automatic surgery |
Patients and families should receive a clear follow-up plan, including which symptoms warrant emergency care, who to contact about valve settings, and when repeat imaging is needed. A second neurosurgical opinion can be reasonable when the diagnosis is uncertain, the proposed operation is complex, or the expected benefit is difficult to estimate.
Hydrocephalus is a treatable neurological disorder, but successful care relies on accurate diagnosis and ongoing review. Adults with progressive walking difficulty, cognitive change, urinary symptoms, persistent headache, or unexplained neurological decline should arrange medical assessment. Clinicians, students, and families can use trusted neurosurgical education and professional discussion resources to deepen their understanding while keeping every treatment decision grounded in an individual specialist evaluation.